Gene · 4680
Papers1,711
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,711
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunophenotypic measurable residual disease monitoring in adult acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. | Front Oncol | 2023 | 36910638 | PubTator, text mining | PubMed |
| Adherent-invasive E. coli - induced specific IgA limits pathobiont localization to the epithelial niche in the gut. | Front Microbiol | 2023 | 36910191 | PubTator, text mining | PubMed |
| Interpretable and context-free deconvolution of multi-scale whole transcriptomic data with UniCell deconvolve. | Nat Commun | 2023 | 36906603 | PubTator, text mining | PubMed |
| Development and Experimental Validation of a Novel Prognostic Signature for Gastric Cancer. | Cancers (Basel) | 2023 | 36900401 | PubTator, text mining | PubMed |
| Effects of Helicobacter pylori adhesin HopQ binding to CEACAM receptors in the human stomach. | Front Immunol | 2023 | 36891299 | PubTator, text mining | PubMed |
| Interactions of pathogenic Escherichia coli with CEACAMs. | Front Immunol | 2023 | 36865539 | PubTator, text mining | PubMed |
| Osthole regulates N6-methyladenosine-modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease. | MedComm (2020) | 2023 | 36845072 | PubTator, text mining | PubMed |
| CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy. | Cancers (Basel) | 2023 | 36831396 | PubTator, text mining | PubMed |
| NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps. | Cancer Cell | 2023 | 36827980 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants. | Stem Cell Reports | 2023 | 36827975 | PubTator, text mining | PubMed |
| Dysregulated lung stroma drives emphysema exacerbation by potentiating resident lymphocytes to suppress an epithelial stem cell reservoir. | Immunity | 2023 | 36822205 | PubTator, text mining | PubMed |
| Mechanisms of host manipulation by Neisseria gonorrhoeae. | Front Microbiol | 2023 | 36819065 | PubTator, text mining | PubMed |
| Spatially resolved transcriptomics revealed local invasion-related genes in colorectal cancer. | Front Oncol | 2023 | 36816947 | PubTator, text mining | PubMed |
| Clinical, biological, and outcome features of P2RY8-CRLF2 and CRLF2 over-expression in pediatric B-cell precursor acute lymphoblastic leukemia according to the CCLG-ALL 2008 and 2018 protocol. | Eur J Haematol | 2023 | 36814093 | PubTator, text mining | PubMed |
| Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients. | PLoS One | 2023 | 36812168 | PubTator, text mining | PubMed |
| Genomic characterization and therapeutic utilization of IL-13-responsive sequences in asthma. | Cell Genom | 2023 | 36777184 | PubTator, text mining | PubMed |
| Blastoid B-Cell Neoplasms: Diagnostic Challenges and Solutions. | Cancers (Basel) | 2023 | 36765805 | PubTator, text mining | PubMed |
| Retraction Note: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. | Oncogene | 2023 | 36765147 | Swiss-Prot, curated | PubMed |
| A mechanistic evaluation of human beta defensin 2 mediated protection of human skin barrier in vitro. | Sci Rep | 2023 | 36755116 | PubTator, text mining | PubMed |
| Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer. | Clin Cancer Res | 2023 | 36749873 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4680/papers?page=16